πŸ‡ΊπŸ‡Έ FDA
Patent

US 8729028

Noggin-derived peptide and use thereof

granted A61KA61K38/00A61P

Quick answer

US patent 8729028 (Noggin-derived peptide and use thereof) held by CAREGEN CO., LTD. expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CAREGEN CO., LTD.
Grant date
Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61P, A61P17/00, A61P17/14